Deerfield Private Design Fund III, L.P.
CIK 1603333
Transactions on file
13
Open-market buys
3
Win rate (buys)
100%
3 scored
Avg % since filing (buys)
+13.4%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 407,132 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 407,132 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 260,992 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 260,992 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 149,238 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 149,238 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 122,990 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | 10%Other | C | 122,990 | $0.00 | — | open → |
| 2025-07-01 | 2025-06-27 | SPRY ARS Pharmaceuticals, Inc. | 10% | Sale | 370,075 | $6.83M | -68.4% | open → |
| 2025-07-01 | 2025-06-27 | SPRY ARS Pharmaceuticals, Inc. | 10% | Sale | 370,074 | $6.83M | -68.4% | open → |
| 2025-08-04 | 2025-07-31 | LRMR Larimar Therapeutics, Inc. | Director10%Other | Buy | 2,599,932 | $8.32M | +13.4% | open → |
| 2025-08-04 | 2025-07-31 | LRMR Larimar Therapeutics, Inc. | Director10%Other | Buy | 3,387,539 | $10.84M | +13.4% | open → |
| 2025-08-04 | 2025-07-31 | LRMR Larimar Therapeutics, Inc. | Director10%Other | Buy | 3,387,529 | $10.84M | +13.4% | open → |
